An FDA panel last week issued its recommendations for pre- and post-market studies of flow diverters used to treat brain aneurysms.
FDA panel issues aneurysm device recommendations
Neurovascular repair
FDA approves Medtronic’s Pipeline Flex aneurysm device
Sequent Medical CEO Wilder bets on MicroBraids
Covidien’s Ev3 logs a pair of legal wins over Appriva, whistleblower
Neurovascular: Covidien begins enrollment in 2 new trials
Covidien snaps up Reverse Medical
FDA OKs return of Covidien’s Pipeline embolism device
Covidien’s next-gen Pipeline embolization lands in Europe
FDA: Covidien Pipeline recall is Class I
Covidien recalls Pipeline, Alligator brain aneurysm devices
Sequent Medical raises $20M Series D for brain aneurysm device
Sequent Medical said it raised a Series D round worth $20 million from its slate of previous investors, led again by Delphi Ventures.
Domain Associates, US Venture Partners and Versant Ventures also participated, Sequent said.
